Measles, Cyclospora-When Should You Be Concerned?

In this post I review the CURRENT outbreaks of preventable illnesses in the United States. I also discuss the significance of significant unlying conditions.

Have you wondered how they know the current cyclospora outbreak in the United States may have started with lettuce at a Taco Bell restaurant?

This article from KFF Health News explains how. Nurses from the local public health department call infected people and ask them about their eating habits.

Can you remember what you ate two weeks ago, the brand name on the package, and where it came from? What restaurant did you go to two weeks ago? If you didn’t order on an app or save your receipt, you might not remember.

Fortunately for the sake of disease tracing, some people do.

Nurses Chase Cyclospora, Aided by Interviews, Fast-Food Receipts — And the Messy Details

By Kate Wells, Aug 4, 2026

A woman holding a phone to her left ear sits in front of a laptop and looks at the screen.
Linda Kim, a nurse with the Washtenaw County Health Department in Michigan, has been helping to investigate the county’s 900-plus cases of cyclosporiasis since mid-June. Public health investigations of foodborne illnesses are complex, and that’s especially the case with cyclosporiasis, because symptoms can take as long as two weeks to appear after someone’s eaten contaminated food. (Kate Wells/KFF Health News)

Listen at this link.

More than 900 people in Washtenaw County, Michigan, have been sickened with cyclosporiasis since mid-June. Linda Kim, a public health nurse, has called more than 100 of them. Almost everyone has said the same thing: It’s excruciating, and one of the worst illnesses they’ve experienced.

But on a Wednesday in July, she called one man who said he wouldn’t mind having it again, actually.

“You’re enjoying the weight loss?” Kim said, laughing as she took notes in a small conference room at the Washtenaw County Health Department building, just outside Ann Arbor. “Well, I’m glad to hear that. At least you got something good out of it!”

Normally, Kim’s supposed to be working downstairs in the clinic, where families wait in gray plastic chairs in the lobby for free or low-cost immunizations. But she hasn’t been there in months.

First, a Measles Outbreak

In March, Kim was transferred to a different department to help deal with a measles outbreak that sickened seven people in the county, five of them children. It was an all-hands-on-deck situation; everyone worked overtime. The state issued an advisory urging families in Washtenaw and surrounding counties to get babies 6 months or older vaccinated ahead of schedule, if possible.

The contact-tracing calls for measles could be contentious, Kim said. People were suspicious, asking her how she knew they had tested positive, or why they should give her any information.

“People were like, ‘Oh, you’re just trying to restrict my life,’ or ‘You’re just trying to get information out of me and get me in trouble,’” she said. “It’s like, no, we’re actually not doing that at all.”

As she tried to explain to them, tracing the spread of the highly contagious virus and publicizing possible exposure sites was an effort to “keep it contained, so it doesn’t become something huge.”

Measles is highly contagious and spreads through the air when an infected person coughs or sneezes.
Then, Cyclospora “Exploded”

The county’s measles outbreak ended in late May. Then in June, reports of cyclosporiasis cases started pouring in — more than 11,000 so far in Michigan, including two deaths. Both people who died had “significant underlying health conditions that may have been impacted by cyclosporiasis and dehydration,” the state health department said on its website Aug. 3.

Health officials aren’t providing more details, department spokesperson Lynn Sutfin said in an email, but are stressing that cyclosporiasis generally isn’t life-threatening and that deaths from it are uncommon in the U.S.

Kim said the cyclosporiasis surveillance has been very different from her experience with the measles outbreak.

Now, people seem eager to divulge even the most graphic details, such as “pooping their beds, and, like, putting down towels and it’s not enough.”

Linda Kim, public health nurse

Since she’s a nurse, such confessions don’t faze her, she said. Still, staffers have hundreds of these calls to make, so they try to keep each conversation under an hour.

“Crunchy or Soft?”

But foodborne illness investigations are complex. Especially for this parasite, cyclospora. Symptoms can take as long as two weeks to appear after people have eaten contaminated food. And no one remembers what they ate two weeks ago, public health staffers said.

The interview process can be extremely detailed. Kim and her colleagues ask people to pull up their restaurant receipts, scroll through purchases on their grocery store apps, even try to recall details such as the exact brand of bagged salad mix they bought, or the type of taco they got at Taco Bell.

“Is that the crunchy one or the soft one?” Kim asked on a recent call, typing on a laptop decorated with cat and vaccine-themed stickers.

Kim has been working with the health department for two years, a period defined by federal funding cuts.

Federal Funding Cuts Hurt

Laina Stebbins, a spokesperson for the Michigan Department of Health and Human Services, said the Trump administration’s sweeping cuts to public health grants eliminated a contract between the state health department and 44 of the state’s 45 local departments that funded 123 full-time employees.

Those cuts also affected the state’s disease surveillance labs, “reducing funding for equipment maintenance contracts, data modernization, and the ability to innovate laboratory processes during emerging disease response,” Stebbins said.

Some of that funding was restored after Michigan won a temporary restraining order against the Trump administration. But Washtenaw’s health department still had to scale back some disease surveillance and outbreak response work. Currently, employees who leave or retire aren’t replaced, except for those on the nursing team, which is hiring but still understaffed.

The county’s Health Equity Council, which aims to reduce health disparities, including in mental health, was shuttered suddenly in early 2025. Nearly a year later, it resumed its work, with funding at least through this September.

An image of a building where the sign on its wall reads, "State of Michigan Department of Health & Human Services."
Staff at the Washtenaw County Health Department in Ypsilanti, Michigan, have been working to trace the sources of the recent cyclospora outbreaks by conducting detailed, often lengthy interviews with hundreds of people. (Kate Wells/KFF Health News)
Slow Response from Federal Public Health

An employee from the Centers for Disease Control and Prevention had been stationed at the department. During the funding chaos, the worker was fired, then rehired, then furloughed.

The federal response to cyclosporiasis has felt frustratingly slow, according to Christina Zilke, a nursing supervisor at the Washtenaw health department.

“It took them forever to say that this was lettuce, and fast-food restaurants were taking it off the shelves before the CDC ever said what it was,” she said.

During a July 14 press call, the deputy director of the CDC’s Division of Foodborne, Waterborne, and Environmental Diseases, Gwen Biggerstaff, said it’s not unusual for it to take a long time to identify a specific source for cyclosporiasis — if it’s identified at all. That’s partly due to the lag time between exposure and the appearance of symptoms, and the complexity of tracing this particular parasite.

Meanwhile, Zilke’s been stocking the coffee station and bringing in pizza, trying to keep up staff morale. It’s not a reward, she said. “It’s more like: ‘Here’s some food for survival. Here’s a break so you don’t quit.’”

Kim, for her part, remains enthusiastic about the job but said it’s been a surreal introduction to a public health career — first measles, now cyclospora.

“If nationally they don’t know what’s going on, how are we locally expected to know what’s going on?” she said. “And also just frustrating to be, like, ‘Wow, I don’t think even our government knows how important public health is.’”

But there’s no time to dwell. She has to move on to the next call, as soon as she can wrap up this one. She gives each person her work number, so people can call or text with any follow-up questions.

KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF—an independent source of health policy research, polling, and journalism. Learn more about KFF.

This article first appeared on KFF Health News and is republished here under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Underlying Health Conditions Explained

One term used in this story you’ve heard before –“people with significant underlying health conditions.” During COVID, these people were known to be at increased risk of severe disease, complications, and death. That’s true of many acute illnesses, not just COVID, cyclospora, or other infections.

What exactly is a significant underlying health condition? Simply put, any medical condition that involves a critical body organ or system-heart, lungs, kidneys, brain. An official definition of “significant underlying health conditions” is

 long-term or chronic medical issues that last for more than one year, require ongoing medical care, and can increase the risk of severe complications from infections like COVID-19. Examples are

  Heart Conditions: Heart failure, coronary artery disease, and cardiomyopathies.

  Chronic Lung Diseases: COPD, moderate-to-severe asthma, and pulmonary fibrosis.

  Diabetes: Type 1 and Type 2 diabetes, particularly with complications.

  Obesity: Having a high body mass index (BMI) that strains organ function.

  Chronic Kidney and Liver Disease: Stage-based kidney disease or chronic liver failure/cirrhosis.

  Immunocompromised States: Active cancer treatments, organ transplants, or HIV.

The “one-year” means they are expected to last at least that long, not that we wait a year before considering them significant. Most of the ones listed become lifelong concerns.

Other significant medical conditions include age-the very young or old, pregnancy, neurological dysfunction, homelessness, and substance abuse.

These are also referred to as Chronic Diseases. However, some chronic diseases do not necessarily increase one’s risk of serious illness.

How do you know if you have one of these conditions? Usually, they are diagnosed when symptoms prompt someone to seek medical attention and undergo an appropriate exam and testing. But sometimes people walk around for years ignoring “minor” symptoms until they become major. By this time, heart, lung, or kidney disease can be in advanced stages, as can cancer.

But that doesn’t mean people without serious underlying conditions are not at risk of getting seriously ill or dying from COVID, measles, cyclospora, influenza, pneumonia, or any other unexpected disease or injury. We all need to be vigilant to protect our health.

Next Steps

If you have a serious chronic disease, how do you protect yourself from acute illnesses that might become severe or life-threatening?

What else do you need to know, and where will you get this information?

If you don’t have a chronic disease now, what do you do to prevent one? Do you wonder what more you could do?

Your physician can help you. Consider asking about screening for the chronic diseases mentioned above.

Review your family medical history. If a close relative has a chronic disease, you may be at increased risk.

Review your use of tobacco, alcohol, and other substances.

Last but not least, we all need to monitor our daily activities-what we eat, how much we sit, how much we move, and our sleep. These are all vitally important to good health, but often ignored.

Exploring the HEART of Health

Thanks to KFF Health News and NPR for this report. The cover photo is by Photo by SpotOn POS on Pexels.com.

You’ve made it through a long post with much information to digest. Take it one step at a time. One can get fatigued with too many good intentions.

I appreciate your time reading this post and invite you to follow this blog and me on social media.

I share information and inspiration to help you transform challenges into opportunities for learning and growth.

Add your name to the subscribe box to be notified of new posts by email. Click the link to read the post and browse other content. It’s that simple. No spam.

I enjoy seeing who is new to Watercress Words. When you subscribe, I will visit your blog or website. Thanks and see you next time.

Dr. Aletha

Understanding GLP-1 Drugs for Weight Loss and Diabetes

Here I review th GLP-1 drugs, approved for managing type 2 diabetes and aiding weight loss, simulate the GLP-1 hormone, promoting fullness and blood sugar control. While they can be effective, they come with risks and side effects, and long-term success requires lifestyle changes, regular exercise, and mental health support, as emphasized by healthcare professionals.

Updated July 3, 2026

This information is current as of the date of original publication or update but may have changed by the time you read this. Do not use this information for diagnosis or treatment purposes. Before making health decisions, discuss with a qualified healthcare professional.

When I was in medical practice, patients asked me for weight loss drugs. There were a few that varied in effectiveness, side effects, and risks. In general, none were effective in significant long-term weight loss.

I also had numerous patients with type 2 diabetes who needed medication to achieve optimal blood sugar levels, but did not want or need insulin. Again, there were several, but most patients needed at least two drugs to lower the glucose to the target level.

Then came the GLP-1 drugs.

GLP-1 medications (glucagon-like peptide-1 receptor agonists) are FDA-approved drugs used to manage type 2 diabetes and chronic weight loss. Popular brands include Wegovy, Ozempic, Mounjaro, and Zepbound, which are generally meant for adults with high BMI (body mass index) or weight-related conditions. 

(Body Mass Index (BMI) is a screening tool that calculates a person’s body fat percentage based on their height and weight. It is calculated by dividing weight in kilograms (kg) by height in meters squared.)

How GLP-1 Drugs Work

  • Appetite Regulation: They mimic the GLP-1 hormone, signaling to the brain that you are full, reducing hunger and calorie intake.
  • Blood Sugar Control: They stimulate insulin release after meals and prevent the liver from producing too much glucose.
  • Slower Digestion: They delay gastric emptying, keeping food in the stomach

However, they are not perfect and have risks.

  • Possible side effects -nausea, vomiting, diarrhea, constipation, and abdominal pain, which often improve over time.
  • Potential for thyroid C-cell tumors (based on animal studies), pancreatitis, kidney issues, and severe gallbladder issues.
  •  Rapid weight loss can cause “GLP-1 face” (loss of facial fat leading to a sagging/wrinkled appearance)
  • costs over $1000 per month, and insurance coverage varies
  • FDA has warned about risks associated with unapproved, compounded versions of these medications.

Taking a GLP-1? Doctors Say Not To Forget About Movement and Mental Health

Severe ankle pain drove Jelon Smart to start taking a weight-loss injection a year and a half ago.

Smart was 285 pounds and worked as a caterer in Savannah, Georgia. After she’d been standing on her feet for long hours, her ankles would be “as swollen as a football,” she said. She was walking with a limp.

An orthopedic doctor diagnosed her with Achilles tendinitis and recommended losing weight to mitigate the symptoms. Smart began taking the brand-name GLP-1 Ozempic.

The appetite suppression resulted in her shedding pounds quickly, at first.

“I lost 30 pounds initially without changing anything,” said Smart, 48. But then she found herself unable to shed additional pounds.

GLP-1 Drugs- Weight Loss Made Easy

GLP-1s have quickly become one of the most popular types of weight loss drug in America. Nearly 1 in 5 people have taken them at some point, according to research from KFF, a health information nonprofit that includes KFF Health News.

But doctors say it takes more than a regular shot for patients to achieve their weight goals in the long run.

Body mass index chart
A BMI OF 30 or more represents obesity. BMI Chart created by Vertex42.com. Used with permission.

Here’s what to know.

The Old-School Rules of Diet and Exercise

Regular exercise, smart food choices, plenty of sleep — those basic, healthy lifestyle choices are not only going to help you lose weight on a weight loss drug but also help you keep it off, said Dafina Allen, an  obesity medicine physician who runs a clinic in Saginaw, Michigan.

For example, some people find that they eat less on a GLP-1, “but they’re not improving their health because they’re not exercising. They’re not improving the quality of the food they’re eating,” Allen said.

The path to weight loss is also guided by hormones, metabolism, and genetics.

After her weight loss on Ozempic plateaued, Smart realized she needed to start moving her body, too.  “I’m in the gym now six days a week,” she said. “I went from 285 to 175” pounds. The swelling and pain in her ankle went away as well.

Photo by Julia Larson on Pexels.com

Mental Health Matters Too

The mind and body are deeply connected. Food and body image can be especially emotional, Allen said. “I can tell you about the patients that I helped lose 50 pounds, that I helped lose 100 pounds, and they still look in the mirror and are not happy.”

The key is seeking help for mental health along the way, said Gerald Onuoha, who practices internal medicine in Nashville, Tennessee. “Making sure that you’re talking to people about your problems, whether it’s a family member or a licensed professional, I think goes a long way,” he said.

Work With a Doctor To Closely Monitor Your Dosage

Onuoha said people can run into serious problems if they increase their GLP-1 dosage too quickly or don’t follow the recommended schedule. He’s seen patients come to the hospital with pancreatitis, gallstones, or acute kidney injury.

 “I always ask patients who are on GLP-1s: How long have they been on them?” he said. “Are they adhering to the directions? Because those things determine whether or not you’re going to have those complications.”

a female physician talking to a male patient
image from LIGHTSTOCK, affiliate

Part of the issue, Allen said, is that GLP-1s are relatively easy to access — and often much cheaper — through online pharmacies or websites, but those providers may not educate patients about their dosage or side effects.

“So they might just go online, find a random company that will ship it to their house, where they don’t even know what dose of the medication they’re taking, or even if the medicine is safe for them as the patient with the medical conditions they have,” she said.

People and Policy-Who Pays for GLP-1s?

GLP-1 drugs can be costly, and most insurance programs — public or private — don’t cover the medications for weight loss.

Medicaid, the government program that covers 69 million Americans, covers GLP-1s for medically accepted conditions like diabetes, but only about a dozen state Medicaid programs cover GLP-1s for obesity treatment, according to KFF.

For older Americans with Medicare, the federal government is planning to allow temporary coverage of GLP-1s for weight loss starting in July.

Katherine Ruppelt at Nashville Public Radio contributed to this report.

HealthQ is a health series from reporters Cara Anthony and Blake Farmer, approachable guides to an unapproachable health care system. It’s a collaboration between Nashville Public Radio and KFF Health News.KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF—an independent source of health policy research, polling, and journalism. Learn more about KFF.

Subscribe to KFF Health News’ free Morning Briefing.

This article first appeared on KFF Health News and is republished here under a Creative Commons Attribution-NoDerivatives 4.0 International License.

Trouble Getting Weight Loss Drugs Covered by Insurance? Here’s What To Know

Images in this Post

The photos in this post are for illustration only and were not in the original article.

Exploring the HEART of Health

I appreciate your time reading this post and invite you to follow this blog and me on social media.

I share information and inspiration to help you transform challenges into opportunities for learning and growth.

Add your name to the subscribe box to be notified of new posts by email. Click the link to read the post and browse other content. It’s that simple. No spam.

I enjoy seeing who is new to Watercress Words. When you subscribe, I will visit your blog or website. Thanks and see you next time.

Use this search box for related posts on this blog or other topics of interest to you.

Dr. Aletha